Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 1
2007 1
2008 4
2009 2
2010 2
2011 5
2012 4
2013 12
2014 3
2015 8
2016 5
2017 2
2018 3
2019 5
2020 3
2021 5
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Introduction to COX inhibitors.
Biava M. Biava M. Future Med Chem. 2018 Aug 1;10(15):1737-1740. doi: 10.4155/fmc-2018-0159. Epub 2018 Jul 18. Future Med Chem. 2018. PMID: 30019919 Free article. No abstract available.
Malaria transmission blocking compounds: a patent review.
Consalvi S, Tammaro C, Appetecchia F, Biava M, Poce G. Consalvi S, et al. Among authors: biava m. Expert Opin Ther Pat. 2022 Jun;32(6):649-666. doi: 10.1080/13543776.2022.2049239. Epub 2022 Mar 11. Expert Opin Ther Pat. 2022. PMID: 35240899 Review.
Overcoming drug resistance for tuberculosis.
Poce G, Biava M. Poce G, et al. Among authors: biava m. Future Microbiol. 2015;10(11):1735-41. doi: 10.2217/fmb.15.76. Epub 2015 Oct 30. Future Microbiol. 2015. PMID: 26516679 Review.
Overcoming drug resistance in TB: an update.
Consalvi S, Poce G, Scarpecci C, Biava M. Consalvi S, et al. Among authors: biava m. Future Microbiol. 2020 Nov;15:1607-1609. doi: 10.2217/fmb-2020-0089. Epub 2020 Nov 20. Future Microbiol. 2020. PMID: 33215545 No abstract available.
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.
Aiello P, Consalvi S, Poce G, Raguzzini A, Toti E, Palmery M, Biava M, Bernardi M, Kamal MA, Perry G, Peluso I. Aiello P, et al. Among authors: biava m. Semin Cancer Biol. 2021 Feb;69:150-165. doi: 10.1016/j.semcancer.2019.08.029. Epub 2019 Aug 24. Semin Cancer Biol. 2021. PMID: 31454670 Review.
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis.
Consalvi S, Poce G, Ghelardini C, Di Cesare Mannelli L, Patrignani P, Bruno A, Anzini M, Calderone V, Martelli A, Testai L, Giordani A, Biava M. Consalvi S, et al. Among authors: biava m. Eur J Med Chem. 2021 Jan 15;210:112983. doi: 10.1016/j.ejmech.2020.112983. Epub 2020 Oct 31. Eur J Med Chem. 2021. PMID: 33168231 Review.
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis.
Poce G, Consalvi S, Venditti G, Alfonso S, Desideri N, Fernandez-Menendez R, Bates RH, Ballell L, Barros Aguirre D, Rullas J, De Logu A, Gardner M, Ioerger TR, Rubin EJ, Biava M. Poce G, et al. Among authors: biava m. ACS Med Chem Lett. 2019 Sep 18;10(10):1423-1429. doi: 10.1021/acsmedchemlett.9b00204. eCollection 2019 Oct 10. ACS Med Chem Lett. 2019. PMID: 31620228 Free PMC article.
65 results